Clinical Trial Update: Nodular Shrinking in Dupuytren Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating nodular shrinking in Dupuytren's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Disease

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Dupuytren's Disease | Phase 2 | Status: RECRUITING